Correlation Between Anebulo Pharmaceuticals and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Citius Oncology,, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Citius Oncology,.
Diversification Opportunities for Anebulo Pharmaceuticals and Citius Oncology,
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Anebulo and Citius is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Citius Oncology, go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Citius Oncology,
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Citius Oncology,. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 2.87 times less risky than Citius Oncology,. The stock trades about -0.07 of its potential returns per unit of risk. The Citius Oncology, is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 107.00 in Citius Oncology, on September 15, 2024 and sell it today you would earn a total of 4.00 from holding Citius Oncology, or generate 3.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Citius Oncology,
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Citius Oncology, |
Anebulo Pharmaceuticals and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Citius Oncology,
The main advantage of trading using opposite Anebulo Pharmaceuticals and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Anebulo Pharmaceuticals vs. Puma Biotechnology | Anebulo Pharmaceuticals vs. Iovance Biotherapeutics | Anebulo Pharmaceuticals vs. Day One Biopharmaceuticals | Anebulo Pharmaceuticals vs. Inozyme Pharma |
| Citius Oncology, vs. Molecular Partners AG | Citius Oncology, vs. MediciNova | Citius Oncology, vs. Anebulo Pharmaceuticals | Citius Oncology, vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |